Stock listing

Cboe Canada:SHRX Sharp Therapeutics Corp. Stock

Canadian listing (Cboe Canada) of Sharp Therapeutics Corp. · home listing TSXV:SHRX

Follow Sharp Therapeutics Corp. into a list and get an email when it puts out news.

Home listing price · TSXV:SHRX

$1.37 CAD 0.00 (0.0%)

Close on Oct 15, 2026 · This listing has no price on 6ix; the price shown is the home listing's, TSXV:SHRX · Data provided by Twelve Data

Sharp Therapeutics Corp. logo
Ticker
Cboe Canada:SHRX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Cboe Canada
Currency
CAD

What changed lately

Latest news

All Sharp Therapeutics Corp. news

Financings

  • Private placement of common shares

    Jul 29, 2026 · US$969,254

    Closed: C$1.36M raised · C$0.91 a share

    Buyers: Newlin Investment Company 1, LLC (subscribed for US$200,000.45)

    Insiders: Newlin Investment Company 1, LLC, wholly owned by director and Chairman William R. Newlin, subscribed for US$200,000.45

    Use of proceeds: General working capital purposes

    Announced Jul 15, 2026 · Closed Jul 29, 2026

  • Conditional share purchase commitment

    Jul 15, 2026

    Cancelled: up to US$10M

    Buyers: STX Partners

    Cancelled Jul 15, 2026

Read by 6ix AI from the company's releases

Sharp Therapeutics Corp. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
15 in the last 12 months · 26 in all · newest Aug 28, 2026 · oldest 2024

Where Sharp Therapeutics Corp. is listed

ListingExchangeCountryCurrency
TSXV:SHRX · Home listingTSXVCanadaCAD
OTC:SHRXFOTCUnited StatesUSD
Cboe Canada:SHRX · This pageCboe CanadaCanadaCAD

Log in to ask 6ix AI your own questions about Sharp Therapeutics Corp.